A Comparison of White and African American Outcomes from a Three-Arm, Randomized, Phase III Multicenter Trial of Advanced or Metastatic Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

A Comparison of White and African American Outcomes from a Three-Arm, Randomized, Phase III Multicenter Trial of Advanced or Metastatic Non-small Cell Lung Cancer

Published:2010-07 Issue:7 Volume:5 Page:993-1000
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Obasaju Coleman K.,Ansari Rafat H.,Socinski Mark A.,Chen Ruqin,Monberg Matthew J.,Catalano Robert B.,Marinucci Donna M.,Liles Darla K.,Ribeiro Maria-Jose,Comis Robert L.,Treat Joseph

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference48 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Screening, diagnosis, and staging of lung cancer;Shepherd;Curr Opin Oncol,1993

3. Chemotherapy for advanced non-small-cell lung cancer;Walling;Respir Med,1994

4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group;BMJ,1995

5. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?;Grilli;J Clin Oncol,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis;JCO Oncology Practice;2021-05

2. Patterns of Care and Survival in Stage III NSCLC Among Black and Latino Patients Compared With White Patients;Clinical Lung Cancer;2019-07

3. Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS Database Study;The Thoracic and Cardiovascular Surgeon;2015-05-18

4. Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2015-05

5. A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer;Cancer Management and Research;2014-10